Long COVID-19 (AAN)
Price: FREE for members and non-members
Session recorded on April 28, 2022
Speaker: Purvi Parikh, MD
Viewers can earn credit by completing the posttest questions.
This program is a collaboration between the American College of Allergy, Asthma and Immunology and the Allergy and Asthma Network.
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 1 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Primary Care Providers
Upon completion of this activity learners should be able to:
1. Recognize signs and symptoms of long haul COVID/PASC
2. Treatment and management of long haul COVID
3. Appropriate referrals for long COVID patients
All identified conflicts of interest have been resolved.
Michael Blaiss, MD, Planner
Disclosures: Consultant: ALK, DBV, Hycor, Merck, Pfizer, Sanofi, Stallergenes Greer, PMD Healthcare
Purvi Parikh, MD, Speaker
Disclosures: Consultant: Allergy and Asthma Network; Owner: Chronic COVID Treatment Center
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance